Created in 2014 (Switzerland), AKLANTO own 2951 sister brands and 17477 competing brands. AKLANTO is owned by NOVARTIS N, listed on the stock exchange of Zurich Its International Securities Identification Number (ISIN) is CH0012005267. AKLANTO belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
NOVARTIS N
(AKLANTO)
over 5 years*
CHF 103.21